225 related articles for article (PubMed ID: 34081226)
1. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
Wachtel H; Fraker DL
Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
[TBL] [Abstract][Full Text] [Related]
2. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
3. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.
Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González-Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román Á; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Andree Furio Collao S; Meneses D; Sampedro-Nuñez MA; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Tenés Rodrigo S; Roa Chamorro R; Jaen Aguila F; Moya Mateo EM; Hanzu FA; Araujo-Castro M
High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):43-53. PubMed ID: 38225508
[TBL] [Abstract][Full Text] [Related]
4. Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade.
Pintus G; Seccia TM; Amar L; Azizi M; Riester A; Reincke M; Widimský J; Naruse M; Kocjan T; Negro A; Kline G; Tanabe A; Satoh F; Rump LC; Vonend O; Fuller PJ; Yang J; Chee NYN; Magill SB; Shafigullina Z; Quinkler M; Oliveras A; Lee BC; Chang CC; Wu VC; Krátká Z; Battistel M; Bagordo D; Caroccia B; Ceolotto G; Rossitto G; Rossi GP
Hypertension; 2024 Jun; 81(6):1391-1399. PubMed ID: 38525605
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers to Guide Medical Therapy in Primary Aldosteronism.
Hundemer GL; Leung AA; Kline GA; Brown JM; Turcu AF; Vaidya A
Endocr Rev; 2024 Jan; 45(1):69-94. PubMed ID: 37439256
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the diagnosis and treatment of primary aldosteronism.
Yoshida Y; Shibata H
Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
[TBL] [Abstract][Full Text] [Related]
7. Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.
Hoshi S; Onagi A; Tanji R; Honda-Takinami R; Matsuoka K; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
BMC Endocr Disord; 2023 Nov; 23(1):243. PubMed ID: 37932696
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: Practical recommendations for treatment and follow-up.
Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
[TBL] [Abstract][Full Text] [Related]
10. Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys.
Cohen JB; Bancos I; Brown JM; Sarathy H; Turcu AF; Cohen DL
Annu Rev Med; 2023 Jan; 74():217-230. PubMed ID: 36375469
[TBL] [Abstract][Full Text] [Related]
11. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment.
Pilz S; Kocjan T; Theiler-Schwetz V; Trummer C
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 37818947
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
[TBL] [Abstract][Full Text] [Related]
14. Reversal of arterial stiffness in medically and surgically treated unilateral primary aldosteronism.
Chen ZW; Liao CW; Pan CT; Tsai CH; Chang YY; Chang CC; Lee BC; Chiu YW; Huang WC; Lai TS; Lu CC; Chueh JS; Wu VC; Hung CS; Lin YH;
J Hypertens; 2024 Mar; 42(3):538-545. PubMed ID: 38088428
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
[TBL] [Abstract][Full Text] [Related]
16. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
Mulatero P; Sechi LA; Williams TA; Lenders JWM; Reincke M; Satoh F; Januszewicz A; Naruse M; Doumas M; Veglio F; Wu VC; Widimsky J
J Hypertens; 2020 Oct; 38(10):1929-1936. PubMed ID: 32890265
[TBL] [Abstract][Full Text] [Related]
17. Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension.
Mansur A; Vaidya A; Turchin A
Am J Hypertens; 2023 Jul; 36(8):455-461. PubMed ID: 37013957
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
19. Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide Study.
Gkaniatsa E; Zverkova Sandström T; Rosengren A; Trimpou P; Olsson DS; Lind M; Muth A; Johannsson G; Ragnarsson O
Hypertension; 2023 Dec; 80(12):2601-2610. PubMed ID: 37855142
[TBL] [Abstract][Full Text] [Related]
20. Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis.
Samnani S; Cenzer I; Kline GA; Lee SJ; Hundemer GL; McClurg C; Pasieka JL; Boscardin WJ; Ronksley PE; Leung AA
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1280-e1289. PubMed ID: 37946600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
